EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 187 filers reported holding EDITAS MEDICINE INC in Q3 2019. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $406,725 | -31.0% | 87,093 | +9.7% | 0.00% | – |
Q1 2024 | $589,355 | -25.0% | 79,428 | +2.3% | 0.00% | – |
Q4 2023 | $786,299 | +29.6% | 77,621 | -0.2% | 0.00% | – |
Q3 2023 | $606,846 | +6.0% | 77,766 | +11.8% | 0.00% | – |
Q2 2023 | $572,502 | -53.6% | 69,563 | -59.1% | 0.00% | – |
Q1 2023 | $1,233,375 | -10.3% | 170,121 | +9.7% | 0.00% | -100.0% |
Q4 2022 | $1,375,372 | +83.4% | 155,059 | +152.9% | 0.00% | – |
Q3 2022 | $750,000 | -59.9% | 61,309 | -61.2% | 0.00% | -100.0% |
Q2 2022 | $1,870,000 | -24.5% | 158,103 | +21.4% | 0.00% | 0.0% |
Q1 2022 | $2,478,000 | -16.9% | 130,268 | +16.0% | 0.00% | 0.0% |
Q4 2021 | $2,983,000 | -12.0% | 112,329 | +36.1% | 0.00% | 0.0% |
Q3 2021 | $3,390,000 | -55.1% | 82,520 | -38.1% | 0.00% | -66.7% |
Q2 2021 | $7,556,000 | +51.8% | 133,411 | +12.6% | 0.00% | +50.0% |
Q1 2021 | $4,977,000 | -13.9% | 118,506 | +43.8% | 0.00% | 0.0% |
Q4 2020 | $5,780,000 | +343.9% | 82,437 | +77.7% | 0.00% | +100.0% |
Q3 2020 | $1,302,000 | -2.8% | 46,404 | +2.5% | 0.00% | 0.0% |
Q2 2020 | $1,339,000 | +79.5% | 45,264 | +26.5% | 0.00% | – |
Q1 2020 | $746,000 | -27.4% | 35,773 | +3.1% | 0.00% | – |
Q4 2019 | $1,028,000 | +39.9% | 34,682 | +7.2% | 0.00% | – |
Q3 2019 | $735,000 | +41.9% | 32,367 | +54.8% | 0.00% | – |
Q2 2019 | $518,000 | +15.1% | 20,915 | +13.6% | 0.00% | – |
Q1 2019 | $450,000 | +9.0% | 18,405 | +1.3% | 0.00% | – |
Q4 2018 | $413,000 | -25.0% | 18,177 | +5.1% | 0.00% | – |
Q3 2018 | $551,000 | +112.7% | 17,291 | +139.3% | 0.00% | – |
Q2 2018 | $259,000 | +11.6% | 7,226 | +3.3% | 0.00% | – |
Q1 2018 | $232,000 | -8.7% | 6,995 | -14.8% | 0.00% | – |
Q4 2017 | $254,000 | +26.4% | 8,211 | -2.9% | 0.00% | – |
Q3 2017 | $201,000 | +38.6% | 8,456 | -2.3% | 0.00% | – |
Q2 2017 | $145,000 | +208.5% | 8,654 | +308.4% | 0.00% | – |
Q1 2017 | $47,000 | +27.0% | 2,119 | -7.1% | 0.00% | – |
Q4 2016 | $37,000 | +164.3% | 2,281 | +116.4% | 0.00% | – |
Q3 2016 | $14,000 | -46.2% | 1,054 | 0.0% | 0.00% | – |
Q2 2016 | $26,000 | – | 1,054 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 185,668 | $5,908,000 | 4.56% |
ARK Investment Management | 2,793,854 | $88,900,000 | 2.69% |
Elmwood Wealth Management, Inc. | 94,067 | $2,993,212,000 | 2.48% |
JS Capital Management LLC | 218,935 | $6,967,000 | 1.92% |
Casdin Capital, LLC | 460,000 | $14,637,000 | 1.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,158,841 | $36,874,000 | 1.32% |
Valiant Capital Management, L.P. | 379,800 | $12,085,000 | 1.07% |
Castle Rock Wealth Management, LLC | 16,315 | $442,000 | 0.70% |
Capital Impact Advisors, LLC | 57,406 | $1,861,000 | 0.64% |
Global Thematic Partners, LLC | 481,568 | $15,323,000 | 0.60% |